338 related articles for article (PubMed ID: 22395764)
1. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation.
Majhail NS; Rizzo JD; Lee SJ; Aljurf M; Atsuta Y; Bonfim C; Burns LJ; Chaudhri N; Davies S; Okamoto S; Seber A; Socie G; Szer J; Van Lint MT; Wingard JR; Tichelli A; ; ; ; ; ; ;
Bone Marrow Transplant; 2012 Mar; 47(3):337-41. PubMed ID: 22395764
[TBL] [Abstract][Full Text] [Related]
2. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation.
Majhail NS; Rizzo JD; Lee SJ; Aljurf M; Atsuta Y; Bonfim C; Burns LJ; Chaudhri N; Davies S; Okamoto S; Seber A; Socie G; Szer J; Van Lint MT; Wingard JR; Tichelli A; ; ; ; ; ; ;
Biol Blood Marrow Transplant; 2012 Mar; 18(3):348-71. PubMed ID: 22178693
[TBL] [Abstract][Full Text] [Related]
3. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation.
Majhail NS; Rizzo JD; Lee SJ; Aljurf M; Atsuta Y; Bonfim C; Burns LJ; Chaudhri N; Davies S; Okamoto S; Seber A; Socie G; Szer J; Van Lint MT; Wingard JR; Tichelli A; ; ; ; ; ; ;
Hematol Oncol Stem Cell Ther; 2012; 5(1):1-30. PubMed ID: 22446607
[TBL] [Abstract][Full Text] [Related]
4. [Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation].
Majhail NS; Rizzo JD; Lee SJ; Aljurf M; Atsuta Y; Bonfim C; Burns LJ; Chaudhri N; Davies S; Okamoto S; Seber A; Socie G; Szer J; Van Lint MT; Wingard JR; Tichelli A; ; ; ; ; ; ;
Rinsho Ketsueki; 2014 Jun; 55(6):607-32. PubMed ID: 24975331
[TBL] [Abstract][Full Text] [Related]
5. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation.
Majhail NS; Rizzo JD; Lee SJ; Aljurf M; Atsuta Y; Bonfim C; Burns LJ; Chaudhri N; Davies S; Okamoto S; Seber A; Socie G; Szer J; Lint MT; Wingard JR; Tichelli A
Rev Bras Hematol Hemoter; 2012; 34(2):109-33. PubMed ID: 23049402
[TBL] [Abstract][Full Text] [Related]
6. International recommendations for screening and preventative practices for long-term survivors of transplantation and cellular therapy: a 2023 update.
Rotz SJ; Bhatt NS; Hamilton BK; Duncan C; Aljurf M; Atsuta Y; Beebe K; Buchbinder D; Burkhard P; Carpenter PA; Chaudhri N; Elemary M; Elsawy M; Guilcher GMT; Hamad N; Karduss A; Peric Z; Purtill D; Rizzo D; Rodrigues M; Ostriz MBR; Salooja N; Schoemans H; Seber A; Sharma A; Srivastava A; Stewart SK; Baker KS; Majhail NS; Phelan R
Bone Marrow Transplant; 2024 Jun; 59(6):717-741. PubMed ID: 38413823
[TBL] [Abstract][Full Text] [Related]
7. International Recommendations for Screening and Preventative Practices for Long-Term Survivors of Transplantation and Cellular Therapy: A 2023 Update.
Rotz SJ; Bhatt NS; Hamilton BK; Duncan C; Aljurf M; Atsuta Y; Beebe K; Buchbinder D; Burkhard P; Carpenter PA; Chaudhri N; Elemary M; Elsawy M; Guilcher GM; Hamad N; Karduss A; Peric Z; Purtill D; Rizzo D; Rodrigues M; Ostriz MBR; Salooja N; Schoemans H; Seber A; Sharma A; Srivastava A; Stewart SK; Baker KS; Majhail NS; Phelan R
Transplant Cell Ther; 2024 Apr; 30(4):349-385. PubMed ID: 38413247
[TBL] [Abstract][Full Text] [Related]
8. Surviving the cure: long term followup of hematopoietic cell transplant recipients.
Majhail NS; Rizzo JD
Bone Marrow Transplant; 2013 Sep; 48(9):1145-51. PubMed ID: 23292238
[TBL] [Abstract][Full Text] [Related]
9. Primary Preventive Care of Hematopoietic Stem Cell Transplantation Survivors: Time to Educate and Empower Recipients and Providers.
Fulcher J; Blanchard AP; Bredeson C; van Walraven C
Transplant Cell Ther; 2023 Feb; 29(2):131.e1-131.e6. PubMed ID: 36336256
[TBL] [Abstract][Full Text] [Related]
10. Long-term Follow-up of Hematopoietic Stem Cell Transplant Survivors: A Focus on Screening, Monitoring, and Therapeutics.
Saunders IM; Tan M; Koura D; Young R
Pharmacotherapy; 2020 Aug; 40(8):808-841. PubMed ID: 32652612
[TBL] [Abstract][Full Text] [Related]
11. Late Effects Surveillance Recommendations among Survivors of Childhood Hematopoietic Cell Transplantation: A Children's Oncology Group Report.
Chow EJ; Anderson L; Baker KS; Bhatia S; Guilcher GM; Huang JT; Pelletier W; Perkins JL; Rivard LS; Schechter T; Shah AJ; Wilson KD; Wong K; Grewal SS; Armenian SH; Meacham LR; Mulrooney DA; Castellino SM
Biol Blood Marrow Transplant; 2016 May; 22(5):782-95. PubMed ID: 26802323
[TBL] [Abstract][Full Text] [Related]
12. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, the Center for International Blood and Marrow Transplant Research, and the American Society of Blood and Marrow Transplantation.
Rizzo JD; Wingard JR; Tichelli A; Lee SJ; Van Lint MT; Burns LJ; Davies SM; Ferrara JL; Socié G
Biol Blood Marrow Transplant; 2006 Feb; 12(2):138-51. PubMed ID: 16443512
[TBL] [Abstract][Full Text] [Related]
13. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
14. Factors associated with adherence to preventive care practices among hematopoietic cell transplantation survivors.
Khera N; Chow EJ; Leisenring WM; Syrjala KL; Baker KS; Flowers ME; Martin PJ; Lee SJ
Biol Blood Marrow Transplant; 2011 Jul; 17(7):995-1003. PubMed ID: 21145404
[TBL] [Abstract][Full Text] [Related]
15. Late Effects Screening Guidelines after Hematopoietic Cell Transplantation (HCT) for Hemoglobinopathy: Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCT.
Shenoy S; Gaziev J; Angelucci E; King A; Bhatia M; Smith A; Bresters D; Haight AE; Duncan CN; de la Fuente J; Dietz AC; Baker KS; Pulsipher MA; Walters MC
Biol Blood Marrow Transplant; 2018 Jul; 24(7):1313-1321. PubMed ID: 29653206
[TBL] [Abstract][Full Text] [Related]
16. Myeloablative hematopoietic cell transplantation for acute lymphoblastic leukemia: analysis of graft sources and long-term outcome.
Tomblyn MB; Arora M; Baker KS; Blazar BR; Brunstein CG; Burns LJ; DeFor TE; Dusenbery KE; Kaufman DS; Kersey JH; MacMillan ML; McGlave PB; Miller JS; Orchard PJ; Slungaard A; Tomblyn MR; Vercellotti GM; Verneris MR; Wagner JE; Weisdorf DJ
J Clin Oncol; 2009 Aug; 27(22):3634-41. PubMed ID: 19581540
[TBL] [Abstract][Full Text] [Related]
17. The preventive health behaviors of long-term survivors of cancer and hematopoietic stem cell transplantation compared with matched controls.
Bishop MM; Lee SJ; Beaumont JL; Andrykowski MA; Rizzo JD; Sobocinski KA; Wingard JR
Biol Blood Marrow Transplant; 2010 Feb; 16(2):207-14. PubMed ID: 19781657
[TBL] [Abstract][Full Text] [Related]
18. Nonmalignant late effects and compromised functional status in survivors of hematopoietic cell transplantation.
Khera N; Storer B; Flowers ME; Carpenter PA; Inamoto Y; Sandmaier BM; Martin PJ; Lee SJ
J Clin Oncol; 2012 Jan; 30(1):71-7. PubMed ID: 22147737
[TBL] [Abstract][Full Text] [Related]
19. Metabolic syndrome and cardiovascular risk in survivors after hematopoietic cell transplantation.
Baker KS; Chow E; Steinberger J
Bone Marrow Transplant; 2012 May; 47(5):619-25. PubMed ID: 21643022
[TBL] [Abstract][Full Text] [Related]
20. Effects of Late Toxicities on Outcomes in Long-Term Survivors of Ex-Vivo CD34
Scordo M; Shah GL; Kosuri S; Herrera DA; Cho C; Devlin SM; Maloy MA; Nieves J; Borrill T; Avecilla ST; Meagher RC; Carlow DC; O'Reilly RJ; Papadopoulos EB; Jakubowski AA; Koehne G; Gyurkocza B; Castro-Malaspina H; Tamari R; Perales MA; Giralt SA; Shaffer BC
Biol Blood Marrow Transplant; 2018 Jan; 24(1):133-141. PubMed ID: 28870777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
